Avesthagen ties up with Cipla

MUMBAI, MAY 12. Avestha Gengraine Technologies Pvt. Ltd. (Avesthagen) and Cipla have embarked on a collaborative biopharmeceuticals development programme for a new generation of targeted therapies.

The partnership is expected to widen with a bouquet of products in the pipeline to cater to other segments such as CVD and Cancer. The partnership is open-ended and the release of the first biotherapeutic is expected in 2-3 years. Under the terms of the sponsored research agreement, Avesthagen will focus on the research and product development all the way through clinical trials, while Cipla will concentrate on scale-up, marketing and distribution.